Concepedia

F. De Marinis

FD

Statistics

Publications

2

Citations

82

H-Index

2

Active since

2022

Affiliations

Seoul National University Hospital(Current)

Sungkyunkwan University

Fondazione IRCCS Istituto Nazionale dei Tumori

Asan Medical Center

Samsung Medical Center

F. De Marinis is an author at Seoul National University Hospital specializing in oncology, pharmacology, and translational biomarker validation.

Publications per year

2022–2025

2

Publications

2

EP08.02-140 MET Biomarker-based Preliminary Efficacy Analysis in SAVANNAH: savolitinib+osimertinib in EGFRm NSCLC Post-Osimertinib

M-j. Ahn, F. De Marinis, L. Bonanno et al. · Journal of Thoracic Oncology · 2022 · 71 citations

, , +9

2O: SAVANNAH: Savolitinib (savo) + osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and METoverexpression (OverExp) and/or amplification (Amp) following progressive disease (PD) on osi

M-J. Ahn, T.M. Kim, L. Bonanno et al. · Journal of Thoracic Oncology · 2025 · 11 citations · Full text

, , +6

1–2 of 2